Development of a voltammetric assay, using screen-printed electrodes, for clonazepam and its application to beverage and serum samples.

This paper describes the development of an electrochemical assay based on screen-printed carbon sensors for the determination of clonazepam in serum and in wine. The cyclic voltammetric behaviour of the drug was investigated and the effects of pH and scan rate on the peak current and peak potential determined. Two reduction peaks were recorded on the initial negative going scan, which were considered to result from the 2e(-), 2 H(+) reduction of the 4,5-azomethine and from the 4e(-), 4 H(+) reduction of the 7-NO2 to a hydroxylamine. On the return positive going scan an oxidation peak was seen, which was considered to result from the 2e(-), 2 H(+) oxidation (O1) of the hydroxylamine to the corresponding nitroso species. At pH 11 the solution of clonazepam was found to turn from clear to yellow in colour and the voltammetric signal of the O1 oxidation process was found to be adsorptive in nature, this was exploited in the development of an adsorptive stripping voltammetric assay. Experimental conditions were then optimised for the differential pulse adsorptive voltammetric measurement of clonazepam in wine and serum samples. It was shown that these analyses could be performed on only 100µL of sample which was deposited on the sensor surface. Mean recoveries of 79.53% (%CV=9.88%) and 88.22% (%CV=14.1%) were calculated for wine fortified with 3.16µg/mL and serum fortified with 12.6µg/mL.

[1]  P. Walson,et al.  Kinetics of Clonazepam in Relation to Electroencephalographic and Clinical Effects , 1983, Epilepsia.

[2]  S. Garcia,et al.  A new method for the simultaneous determination of 1,4-benzodiazepines and amfepramone as adulterants in phytotherapeutic formulations by voltammetry. , 2010, Forensic science international.

[3]  J. Hart,et al.  Development of an electrochemical assay for 2,6-dinitrotoluene, based on a screen-printed carbon electrode, and its potential application in bioanalysis, occupational and public health. , 2003, Biosensors & bioelectronics.

[4]  M. Mahowald,et al.  Sleep and sex: what can go wrong? A review of the literature on sleep related disorders and abnormal sexual behaviors and experiences. , 2007, Sleep.

[5]  L. Hernandez,et al.  Determination of clonazepam by flow injection analysis. , 1988, The Analyst.

[6]  C. Müller,et al.  Do pharmaceuticals affect freshwater invertebrates? A study with the cnidarian Hydra vulgaris. , 2003, Chemosphere.

[7]  Hao Chen,et al.  Investigation of some biologically relevant redox reactions using electrochemical mass spectrometry interfaced by desorption electrospray ionization , 2012, Analytical and Bioanalytical Chemistry.

[8]  Kevin C. Honeychurch,et al.  Screen-printed electrochemical sensors and biosensors for monitoring metal pollutants , 2012 .

[9]  H. Eftekharian,et al.  Clonazepam for the Management of Anxiety Associated with Oral Surgery: A Randomized Double-blind Controlled Trial , 2012 .

[10]  R. Gaensslen,et al.  Analytical developments in toxicological investigation of drug-facilitated sexual assault , 2003, Analytical and bioanalytical chemistry.

[11]  A. Collier Pharmaceutical Contaminants in Potable Water: Potential Concerns for Pregnant Women and Children , 2007, EcoHealth.

[12]  J. Micallef,et al.  Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey , 2012, Fundamental & clinical pharmacology.

[13]  J. Hart,et al.  The Electrochemical Behavior of Nitrazepam at a Screen-Printed Carbon Electrode and Its Determination in Beverages by Adsorptive Stripping Voltammetry , 2009 .

[14]  S. Rath,et al.  Boron‐Doped Diamond Electrode Coupled to Liquid Chromatography: Application to Simultaneous Determination of Benzodiazepines , 2010 .

[15]  F. Musshoff,et al.  Knock-out drugs: their prevalence, modes of action, and means of detection. , 2009, Deutsches Arzteblatt international.

[16]  A. Bisdorff Management of vestibular migraine , 2011, Therapeutic advances in neurological disorders.

[17]  B. Habibi,et al.  Silver nanoparticles/multi walled carbon nanotubes nanocomposite modified electrode: Voltammetric determination of clonazepam , 2014 .

[18]  F. Questel,et al.  Chemical submission: results of 4-year French inquiry , 2009, International Journal of Legal Medicine.

[19]  J. Gates,et al.  Benzodiazepines in epilepsy: pharmacology and pharmacokinetics , 2008, Acta neurologica Scandinavica.

[20]  P. Pini Addiction , 1996, The Lancet.

[21]  M. Lader,et al.  Usage of benzodiazepines: A review , 2010, International journal of psychiatry in clinical practice.

[22]  T. Browne Clonazepam. A review of a new anticonvulsant drug. , 1976, Archives of neurology.

[23]  W. Agras,et al.  Clomipramine, Clonazepam, and Clonidine Treatment of Obsessive‐Compulsive Disorder , 1992, Journal of clinical psychopharmacology.

[24]  L. Hernandez,et al.  Voltammetric Studies of Psychotropic Drugs with Nitro-Groups Determination of Clonazepam in Urine by Adsorptive Stripping Voltammetry , 1991 .

[25]  Vânia Calisto,et al.  Psychiatric pharmaceuticals in the environment. , 2009, Chemosphere.

[26]  Kevin C.. Honeychurch Thick-film biosensors , 2012 .

[27]  R. Lo Pharmacology of chlordiazepoxide (Librium). , 1961 .

[28]  M. Lader Benzodiazepine dependence , 1984, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[29]  P. Grantham Benzodiazepine abuse , 1987, British journal of hospital medicine.

[30]  J. R. Painter,et al.  Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. , 2000, Journal of affective disorders.

[31]  M. Lader Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? , 1999, European Neuropsychopharmacology.

[32]  J. Hart,et al.  Electrocatalytic behaviour of citric acid at a cobalt phthalocyanine-modified screen-printed carbon electrode and its application in pharmaceutical and food analysis , 2010, Analytical and bioanalytical chemistry.

[33]  T. R. Browne CLONAZEPAM … , 2022, Reactions weekly.

[34]  M. Scott-ham,et al.  Toxicological findings in cases of alleged drug-facilitated sexual assault in the United Kingdom over a 3-year period. , 2005, Journal of clinical forensic medicine.

[35]  J. Hart,et al.  The redox behaviour of diazepam (Valium®) using a disposable screen-printed sensor and its determination in drinks using a novel adsorptive stripping voltammetric assay. , 2013, Talanta.

[36]  Stephanie C. Licata,et al.  Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond , 2008, Pharmacology Biochemistry and Behavior.

[37]  L P Longo,et al.  Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives. , 2000, American family physician.

[38]  R. Kakde,et al.  Stability-indicating RP-HPLC method for the simultaneous determination of escitalopram oxalate and clonazepam. , 2013, Journal of chromatographic science.

[39]  M. Lader,et al.  Benzodiazepines — Panacea or Poison? , 1981, The Australian and New Zealand journal of psychiatry.

[40]  J. Hart,et al.  Voltammetric determination of 2-, 3- and 4-chloroaniline in mixtures , 1981 .